U.S., Feb. 4 -- An application to own the trademark for 'RYGOLVYN' has been filed on Feb. 03, 2024.
Owner(s):
Celgene Corporation; Route 206 & Province Line Road, , NEW JERSEY
Goods and/or Services:
For: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ...